Conversation

Replying to
12/ Condition A that represents say a -1% drag on the GDP (ie fixing it would add 1% to growth) goes unaddressed because there is no way to privately make a sweet profit off it.
1
3
13/ While Condition B, that is a 10th place rounding error in GDP terms gets a huge amount of attention/resources because it has efficient private market development potential. Call these "charismatic diseases."
1
5
14/ A charismatic disease/condition is 3 things: a) Easy to market (strong "brands" in symptom terms) b) Easy to dramatize via relateable life narratives ("the American dream, but with diabetes") c) Most importantly: good for drive-by interventions instead of open-ended care
3
13
15/ Charismatic diseases are (Carsean) finite-game diseases where there is such a thing as a clear win condition (or escalation sequence thereof) marketable as a "cure narrative." This does not mean the condition is necessarily curable, just that there's an tree of things to try
1
6
16/ By contrast, infinite game diseases/conditions that require open-ended care relationships are a systemic blindspot. They are hard to privatize, and a system that only targets what is privatizable tends to just give up and let sufferers just live awful lives till they die
2
6
17/ Again, just an observation. Draw your own conclusions about whether tradeoffs made by other countries are better or worse. The point is, "the US has the best healthcare" is a very narrow claim: "best healthcare that a system based on privatizing diseases can deliver"
3
4
18/ Equally, resist the temptation to write off advances made by other countries simply because they aren't accompanied by the innovation theater of the US: patents, big fortunes, miraculous-seeming outcomes for a few.
1
6
19/ Non-private innovations LOOK different: large-scale assembly line cataract operations at "eye camps" in India for example. Or of course, immunization/vaccination.
1
8
20/ The US used to lead on those fronts too about a century ago (eg. Rockefeller foundation work on eliminating hookwork in the US south), but now mostly that's left to "poor" countries.
1
7
21/ tldr of the thread: Don't buy into naive arguments that the US healthcare system is "best in the world" and if your experience of it sucks, it's only because because "other countries free-ride" and you didn't buy enough Big Pharma shares.
2
5
22/ Addendum to point 12: In some cases a net negative societal health condition may be "negatively privatizable" where some other sector (sugar, tobacco) has a stronger incentive to keep the condition alive than the healthcare sector does to cure it for profit.